With Africa being a favourite playground for the pharmaceutical industry, it became critical for scientist, researcher and activist Fahrie Hassan to not only investigate blatant and hidden conflicts of interest in South Africa (and globally), but to expose the complex dynamics that lead to often shocking decisions about health, especially during the last three years. In this Conflicts of Interest Masterclass, he talks to Shabnam Palesa Mohamed about conflicts of interest in the South African Department of Health, and the economic hitmen role of organisations like the Bill and Melinda Gates Foundation, the CDC, US AID, PEPFAR, and the Clinton Health Access Initiative (CHAI), in capturing health and democracy. ------------------------------------ Join The Conversation! | https://trialsitenews.com/ ... https://www.youtube.com/watch?v=qUqc91HUy3E

Join The Conversation! | https://trialsitenews.com/ Story | Australian SuperDome to be Used to Herd 24,000 High Schoolers to Receive Pfizer Vaccine—Told a ‘Golden Opportunity’ 24,000 children will be “ushered” into Sydney’s “Super Dome” also known as “Qudos Bank Arena” for a mass high school student vaccination event. According to an Australian government official, the time is now to get “as many jabs in the arms as possible.” The state government of New South Wales (NSW) was planning on busing the high school students from western and south western suburbs to what they refer to as “mass vaccination hubs,” moving forward with an aggressive program of mass vaccination. Article Link | https://trialsitenews.com/australian-superdome-to-be-used-to-herd-24000-high-schoolers-to-receive-pfizer-vaccine-told-a-golden-opportunity/ Story | Pfizer’s Phase 2/3 ‘COVID Pill Study’ Reveals Potential Antiviral Treatment (PF-07321332) Under Investigation The race is on for the clinical development of the “COVID-19 pill,” an orally administered antiviral medication for early treatment that primary care providers have screamed about for over 1.5 years now. Article Link | https://trialsitenews.com/pfizers-phase-2-3-covid-pill-study-reveals-potential-antiviral-treatment-pf-07321332-under-investigation/ ... https://www.youtube.com/watch?v=4lzJIlgNj68

Join The Conversation! | https://trialsitenews.com/ “The Magic Mushroom” – or its key ingredient, Psilocybin – appears to be out in the lead in the modern wave of psychedelic research. Alongside the high-profile Phase II trial results from Compass Pathways (CMPS, profiled previously on TrialSite News), a handful of other early studies are progressing, or close to starting: Usona Institute, Filament Health, Numinus (NUMI), Diamond Therapeutics, TheraPsil. ... https://www.youtube.com/watch?v=g7_QRVITlv0

Goa Game Changer: Indian State’s Health Authority Approves & Distributes #Ivermectin & #Doxycycline to Treat #COVID19 as Prophylaxis: Goa’s Chief Minister Pramod Sawant alongside State Health Minister Vishwajit Rane launched the ‘Home Isolation Kit’ to combat COVID-19. Apparently, the Indian state was influenced by Australia’s Dr. Thomas Borody and his combination treatment involving Ivermectin and Doxycycline (and zinc) targeting SARS-CoV-2, the virus behind COVID. Dr. Tarek Alam at the Bangladesh Medical College has also demonstrated the efficacy of the treatment in a hospital-approved case series study and is now conducting a randomized controlled study in that country. Back to beautiful southwestern India in Goa, calling it a “game-changer,” the Health Minister of this small Indian state is targeting the complete eradication of the virus in a people-centric home-based program. COVID-19 in Goa HTTPS://WWW.TRIALSITENEWS.COM/GOA-GAME-CHANGER-INDIAN-STATES-HEALTH-AUTHORITY-APPROVES-DISTRIBUTES-IVERMECTIN-DOXYCYCLINE-TO-TREAT-COVID-19-AS-PROPHYLAXIS/ Regeneron Submits Request for FDA EUA for REGN-COV2 in Head to Head Competition with Eli Lilly: Regeneron reported that subsequent to the New York-based company’s discussions with regulatory authorities, they have submitted a request to the U.S. Food and Drug Administration for an Emergency Use Authorization (EUA) for their investigational REGN-COV2 investigational antibody combination for COVID-19. This was one of the experimental therapies administered to POTUS at Walter Reed Medical Center. Under their agreement with the U.S. government for the initial doses of REGN-COV2, if an EUA is granted the government has committed to making these doses available to the American people at no cost and would be responsible for their distribution. At this time, there are doses available for approximately 50,000 patients, and the company expects to have doses available for 300,000 patients in total within the next few months. The company received $450m from the U.S. federal government for advanced purchases and secured ongoing support from NIAID. Eli Lilly just submitted a request for an EUA for their monotherapy monoclonal antibody called LY-CoV555. HTTPS://WWW.TRIALSITENEWS.COM/REGENERON-SUBMITS-REQUEST-FOR-FDA-EUA-FOR-REGN-COV2-IN-HEAD-TO-HEAD-COMPETITION-WITH-ELI-LILLY/ Nitazoxanide Used Off Label in Laredo, TX, to Successfully Treat COVID-19: Now Clinical Trials! A Laredo, Texas, area physician, Dr. Asuncion Ramos Soriano, was recently profiled in local media discussing a novel clinical trial in that part of deep southern Texas. After training back east at NYU and Johns Hopkins, Dr. Soriano has been caring for people along the border here for 25 years. As this part of Texas gets exposed to v ... https://www.youtube.com/watch?v=H86_lG0bN0g